Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $67.56 Analyst target: $65.38 Upside: -3.23%
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.